For Investors & Acquirers
When real capital is at risk, a patent portfolio is only as valuable as it is defensible. We help investors, acquirers, and strategic buyers understand what they are actually buying.
Many patent attorneys ignore the transaction market. It is lucrative, intellectually demanding, and often leads to recurring relationships — and it rewards counsel who can evaluate both the legal strength and the underlying technology.
For medical, AI-enabled, and advanced technology targets, the hardest diligence questions are technical: Does the portfolio actually cover the product? Are the claims valid over the real prior art? Is there freedom to operate? A reviewer fluent in the domain answers those questions with far more confidence.
Who We Support
Venture and growth investors assessing IP strength before and between financing rounds.
Strategic and corporate acquirers integrating technology and portfolios into existing programs.
Sponsors underwriting technology-driven targets and platform investments.
Operating companies acquiring capabilities, products, or defensive IP positions.
Scope of Review
Why It Leads to Recurring Work
Funds and acquirers who find a reviewer that genuinely understands medical and AI-enabled technology tend to return — for the next deal, the next portfolio question, and ongoing counsel to portfolio companies.
Engage for a Transaction
Schedule a confidential consultation to discuss the target technology, timeline, and scope of review.
Request a Confidential Consultation